[Antilipemic effect of bezafibrate in patients with hyperlipoproteinemia type IIB and IV].
D001629:Bezafibrate / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D006953:Hyperlipoproteinemia Type IV / Q000188:drug therapy*
D001629:Bezafibrate
Działanie przeciwlipemiczne bezafibratu u chorych z hyperlipoproteinemia IIB i IV.